Browsing by Author Yiu, WH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 29 to 48 of 60 < previous   next >
TitleAuthor(s)Issue Date
 
Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.
Journal:PLoS ONE
Wu, HJYiu, WHLi, RXWong, DWLLeung, JCKChan, LYYZhang, YLian, QLin, MTse, HFLai, KNTang, SCW
2014
 
Misaligned Expectations on Integrative Medical Service for Diabetes and Diabetic Kidney Disease – A Comparative Focus Group Series of Patients and Physicians
Proceeding/Conference:Global Advances in Health and Medicine
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLi, BLok, WYLi, HXue, RChan, YYLeung, JCKLam, TPLai, KNTang, SCW
2020
 
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
Journal:Mediators of Inflammation
Chan, GCWYiu, WHWu, HWong, WLDLin, MHuang, XRLan, HYTang, SCW
2015
 
N-acetyl-seryl-aspartyl-lysyl-proline Mediates the Anti-fibrotic Properties of Captopril in Unilateral Ureteric Obstructed BALB/C Mice.
Journal:Nephrology
Chan, GCWWU, HCHAN, KWYiu, WHZou, WHuang, XRLan, HYLai, KNTang, SCW
2018
 
New insights into fibrotic signaling in renal cell carcinoma
Journal:Frontiers in Cell and Developmental Biology
Chen, JYYiu, WHTang, PMKTang, SCW
21-Feb-2023
 
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
Journal:BMC Complementary Medicine and Therapies
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLI, BLOK, SWYLI, HXUE, RChan, LYYLeung, JCKLam, TPLai, KNTang, SCW
2020
 
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
Journal:Frontiers in Pharmacology
Chan, KWYu, KYYiu, WHXUE, RLOK, WYLI, HZOU, YMA, JLai, KNTang, SCW
2022
 
PRAgmatic Clinical Trial Design of Integrative MediCinE (PRACTICE): A Focus Group Series and Systematic Review on Trials of Diabetes and Kidney Disease
Journal:Frontiers in Medicine
Chan, KWLee, PWLeung, CPSLaw, YKGao, LChan, GCWYiu, WHLam, TPTang, SCW
2021
 
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling
Journal:Clinical Science
Yiu, WHLi, YLok, SWYChan, KWChan, LYYLeung, JCKLai, KNTsu, JHLChao, JHuang, XRLan, HYTang, SCW
2021
 
Protein overload induces renal proximal tubular epithelial cell apoptosis by down-regulating WNT/β-catenin signalling
Proceeding/Conference:Journal of the American Society of Nephrology
Wong, DWLYiu, WHWu, HLi, RLeung, JCKChan, LYYLai, KNTang, SCW
2013
 
Role of bone morphogenetic protein-7 (BMP7) in diabetic tubulopathy
Proceeding/Conference:Journal of the American Society of Nephrology
Li, RYiu, WHWu, HLin, MWong, DWLChan, LYYLeung, JCKLai, KNTang, SCW
2013
 
Role of bone morphogenetic protein-7 in renal fibrosis
Journal:Frontiers Physiology
LI, RYiu, WHTang, SCW
2015
 
Role of Renal Tubular Wnt/Beta-catenin in Proteinuric Kidney
Proceeding/Conference:Hong Kong Society of Nephrology Annual Scientific Meeting 2018
Yiu, WH
2018
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:International Congress of Chinese nephrologists
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLI, BLI, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Journal of the American Society of Nephrology
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
Journal:BMJ Open
Chan, KWIp, TPKwong, ASKLui, SLChan, GCWCowling, BJYiu, WHWong, DWLLiu, YFeng, YTan, KCBChan, LYYLeung, JCKLai, KNTang, SCW
2016
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Hong Kong Medical Journal
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2018
 
Semi-individualised Chinese medicine treatment for diabetic kidney disease - from users' perspectives to SCHEMATIC trial interim result and potential mechanism.
Proceeding/Conference:Good Practice in Traditional Chinese Medicine Research Association, London.
Chan, KWKwong, ASChan, GCLeung, CPYiu, WHLui, SLIp, TPCowling, BJWong, DWLi, BLi, YFeng, YChan, LYLeung, JCKTan, KCBWong, VCLai, KNTang, SCW
2017
 
Semi-individualised Chinese Medicine Treatment for Diabetic Kidney Disease – From users’ perspectives to SCHEMATIC trial interim result and potential mechanisms
Proceeding/Conference:Advances in Integrative Medicine
Chan, KWKwong, ASKChan, GCWLeung, CPSYiu, WHLui, SLIp, TPCowling, BJWong, WLDLi, BLi, YFeng, YChan, YYLeung, JCKTan, KCBWong, CWVLai, KNTang, SCW
2019
 
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
Journal:Frontiers in Physiology
Yiu, WHChan, KWChan, LYYLeung, JCKLai, KNTang, SCW
2021
Showing results 29 to 48 of 60 < previous   next >